Senate
93rd General Assembly (2021 Regular)
Passed
SB505
To Mandate The Coprescription Of An Opioid Antagonist Under Certain Conditions; And To Amend The Naloxone Access Act.
To Mandate The Coprescription Of An Opioid Antagonist Under Certain Conditions; And To Amend The Naloxone Access Act.
Bill Summary
To Mandate The Coprescription Of An Opioid Antagonist Under Certain Conditions; And To Amend The Naloxone Access Act.
Influence Proximity
1st Degree Direct
2nd Degree Shared
3rd Degree Extended
Network Filters
Bill Documents
Last Updated
Passed
Apr 13, 2021
Apr 13, 2021